Isimo sesexwayiso sekhampasi siluhlaza: Ukuze uthole isimo sesexwayiso sekhampasi ye-UMMS yakamuva, izindaba nezinsiza, sicela uvakashele umassmed.edu/coronavirus
Njengengxenye yohlelo lweNational Institutes of Health's Rapid Diagnostic Acceleration (RADx), ucwaningo lwesikhathi eside olwabhalwa ngabacwaningi base-University of Massachusetts Medical School luveze ukuthi ukuhlolwa kwe-PCR kanye nokuhlolwa kwe-antigen okusheshayo kwe-SARS-CoV-2 kuyasiza ekutholeni. izifo Isebenza ngokulinganayo.Nikeza okungenani kabili ngeviki.
Ngokusho kwe-NIH press release, nakuba ukuhlolwa kwe-PCR yomuntu siqu kubhekwa njengezinga legolide, kuzwela kakhulu kunokuhlolwa kwe-antigen, ikakhulukazi ezigabeni zokuqala zokutheleleka, kodwa imiphumela ibonisa ukuthi lapho kwenziwa njalo njengengxenye yohlelo lokuhlola, kokubili izindlela zokuhlola zizwela kakhulu.Ukuzwela kungafinyelela ku-98%.Lezi yizindaba ezinhle ezinhlelweni ezibanzi zokuvimbela, ngoba ukuhlolwa kwe-antigen endaweni yokunakekelwa noma ekhaya kunganikeza imiphumela esheshayo ngaphandle kwencwadi kadokotela futhi kubiza kancane kunokuhlola elabhorethri.
Ucwaningo lwanyatheliswa ku- "Journal of Infectious Diseases" ngoJuni 30. Abacwaningi abavela eNyuvesi yase-Illinois e-Urbana-Champaign, i-Johns Hopkins School of Medicine, kanye ne-National Institute of Biomedical Imaging and Bioengineering ababhale leli phepha yilaba: UProfesa Ohlangene Wezokwelapha Laura L. ·Gibson (Laura L. Gibson);U-Alyssa N. Owens, Ph.D., Umdidiyeli Wocwaningo;UJohn P. Broach, MD, MBA, MBA, Umsizi Woprofesa Wezokwelapha Eziphuthumayo;Bruce A. Barton, PhD, Population and Professor of Quantitative Health Sciences;Peter Lazar, umthuthukisi wedatha yesicelo;kanye noDavid D. McManus, MD, uRichard M. Haidack uProfesa Wezokwelapha, uSihlalo Wezokwelapha kanye noProfesa.
UDkt. Bruce Tromberg, uMqondisi we-NIBIB, inkampani engaphansi kwe-NIH, uthe: “Ukuhlola ama-antigen ngokushesha ekhaya izikhathi ezimbili kuya kwezintathu ngesonto kuyindlela enamandla futhi elula yokuthi abantu bahlole ukutheleleka nge-COVID-19.“Ngokuvulwa kabusha kwezikole namabhizinisi, ubungozi bokutheleleka komuntu bungashintsha nsuku zonke.Ukuhlolwa okuqhubekayo kwe-antigen kungasiza abantu ukuthi balawule le ngozi futhi bathathe isinyathelo ngokushesha ukuvimbela ukusabalala kwaleli gciwane.”
Abacwaningi baqoqe izinhlobo ezimbili zama-swabs amakhala kanye namasampula amathe kubasebenzi nabafundi ababambe iqhaza ngesikhathi sohlelo lokuhlolwa kwe-COVID-19 eNyuvesi yase-Illinois e-Urbana-Champaign izinsuku eziyi-14 zilandelana.Okukodwa kokuswayipha emakhaleni komhlanganyeli ngamunye kwathunyelwa elabhorethri yase-Johns Hopkins University ukuze kubhekwe ukukhula kwegciwane eliphilayo esikweni kanye nokukala cishe isikhathi isihloko esingadlulisela ngaso ukutheleleka kwabanye.
Abacwaningi babe sebeqhathanisa izindlela ezintathu zokutholwa kwe-COVID-19: ukuhlolwa kwe-PCR yamathe, ukuhlolwa kwe-PCR yesampula yamakhala, kanye nokuhlolwa kwe-antigen yesampula yamakhala ngokushesha.Babala ukuzwela kwendlela ngayinye yokuhlola ukuthola i-SARS-CoV-2 futhi balinganisa ukuba khona kwegciwane eliphilayo phakathi namasonto amabili okutheleleka.
Lapho abacwaningi bebala ukuzwela kokuhlolwa ngokusekelwe kusigqi sokuhlola njalo ezinsukwini ezintathu, babike ukuthi noma ngabe basebenzisa ukuhlolwa kwe-antigen okusheshayo noma ukuhlolwa kwe-PCR, ukuzwela kokuthola ukutheleleka kwakungaphezu kwama-98%.Lapho behlola kuphela imvamisa yokutholwa kanye ngesonto, ukuzwela kokutholwa kwe-PCR yekhala namathe kwakusephezulu, cishe ku-98%, kodwa ukuzwela kokutholwa kwe-antigen kwehle kwaya ku-80%.
"Inselelo ekuchazeni imiphumela yokuhlolwa kwe-PCR noma i-antigen ukuthi ukuhlolwa okuqondile kungase kungabonisi ukuba khona kwezifo ezithathelwanayo (ukucaciswa okuphansi) noma kungase kungalitholi igciwane eliphilayo kusampula (ukuzwela okuphansi), ngokulandelana," kusho umholi ohlangene uDkt. Gibson.I-RADx Tech yocwaningo lomtholampilo oluyisisekelo.
“Okuhlukile kwalolu cwaningo ukuthi sibhangqa i-PCR nokutholwa kwe-antigen nesiko legciwane njengophawu oluthathelwanayo.Lo mklamo wocwaningo uveza indlela engcono kakhulu yokusebenzisa uhlobo ngalunye lokuhlola, futhi unciphisa ubungozi bokusolwa i-COVID-19 Isiguli sichaza umthelela wenselele yemiphumela yaso.”
UDkt. Nathaniel Hafer, umsizi kaprofesa wezokwelapha zamangqamuzana nomseshi oyinhloko we-RADx Tech Study Logistics Core, uthe: “Njengesibonelo somthelela womsebenzi wethu, idatha esiyiqoqayo isiza ekunikezeni i-CDC ulwazi olumayelana nabantu abahlukahlukene.”
UDkt. Hafer ukhombise indima ebalulekile ye-UMass School of Medicine ekwakhiweni, ekusetshenzisweni nasekuhlaziyeni kwalokhu kuhlolwa kokuzwela.Uncome ikakhulukazi ithimba labacwaningi le-University of Massachusetts Medical School eliholwa uDkt. Broach, okuhlanganisa nomqondisi wephrojekthi u-Gul Nowshad kanye netilosi yocwaningo uBernadette Shaw-ngeqhaza labo ekuqapheliseni abahlanganyeli bekude ocwaningweni endlini yokulala Iqhaza elibalulekile eNyuvesi. yase-Illinois.
Umbiko ohlobene ovela Ezindabeni ze-UMassMed: Ngesikhathi uKhongolose evakashele ekhempasini ye-NIH, uhlelo lwe-RADx lwagcizelelwa.I-UMass Medical School isiza ukuhola i-NIH RADx ukusheshisa ubuchwepheshe obusha bokuhlola i-COVID.Izindaba ezisematheni: Isikole iMass Medical School sithola uxhaso lwe-NIH luka-$100 million ukukhuthaza ukuhlolwa kwe-COVID-19 okusheshayo nokufinyelelekayo
Questions or comments? Email: UMMSCommunications@umassmed.edu Tel: 508-856-2000 • 508-856-3797 (fax)
Isikhathi sokuthumela: Jul-14-2021